Extended release medications are designed to release their active ingredients gradually over an extended period, rather than all at once. In the context of bariatric surgery, this is significant because the changes in the digestive system can affect how these medications are absorbed.
After undergoing bariatric surgery, the stomach size is reduced, and the way food moves through the digestive tract changes. In particular, medications that are normally absorbed over time can behave differently. For instance, if these medications rely on the full functioning of the stomach and intestines to be absorbed properly, their effectiveness may be reduced. This occurs because the altered anatomy and the speed at which food and medications pass through the digestive system can lead to either quicker absorption or altered levels of the medication in the bloodstream.
With extended release medications, the formulation is designed to dissolve slowly. However, the reduced stomach size and changes in gut motility after surgery mean that these medications may not stay in the digestive tract long enough for full absorption. This can lead to inconsistent medication levels in your body, potentially resulting in less effectiveness or increased side effects.
For individuals after bariatric surgery, timing becomes crucial. The specific timing for taking these medications may need to be adjusted because they might have a different onset of action compared to before surgery. Moreover, variations in individual responses can also occur; for some, the extended release effect might still work adequately, while others may find diminished effects due to faster gastric emptying.
Ultimately, the change in how medications are absorbed can impact the management of health conditions that require consistent levels of medication. This situation emphasizes the need for close monitoring of how extended release medications function after bariatric surgery.
